Position history for BlackRock, Inc.'s holdings in SPYRE THERAPEUTICS INC
BlackRock, Inc. holds 5.5M shares of SYRE (SPYRE THERAPEUTICS INC), worth $278.5M as of 2026-Q1. The position was decreased (-0.0% shares). SYRE represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$278.5M
Current Shares
5.5M
Total Value Change
+$199.3M
Total Shares Change
+2.1M
Other major holders of SYRE: FMR LLC, RTW INVESTMENTS, LP
Decreased |
| 5.5M |
-0.0% |
| $278.5M |
| 0.0% |
| $40.07 |
0 |
| 2025-Q4 | Increased | 5.5M | +38.6% | $180.9M | 0.0% | $31.88 | 40 |
| 2025-Q3 | Decreased | 4M | -0.6% | $66.8M | 0.0% | $16.36 | 0 |
| 2025-Q2 | Increased | 4M | +12.2% | $60M | 0.0% | $15.22 | 33 |
| 2025-Q1 | Increased | 3.6M | +5.1% | $57.6M | 0.0% | $17.94 | 31 |
| 2024-Q4 | New | 3.4M | - | $79.1M | 0.0% | $22.54 | 41 |